The optimal control and management of the patients affected by urothelial bladder cell carcinoma (UC) is principally contingent on appropriate risk group stratification based on the correct assessment of biological and clinical features [1] . Various pathological, clinical and molecular parameters have been proposed over the past few years for predicting patient outcome, but no single standard prognostic factor can be used to plan a correct follow-up schedule in these patients [2] . The lack of our clinical methods to predict disease recurrence or progression has led to the search for methods that combine existing clinical, pathological and laboratory data with complex mathematical models. For this reason, artificial neural networks (ANNs) have been introduced into clinical practice [3] . To date, however, the ANNs have only been used rarely in urological oncological diseases [4] . We have developed a neural network for predicting recurrence-free probability in patients with superficial UC, carried out in accordance with the results of univariate and multivariate analyses. ANN setup was carried out by using the commercially available software program Neural Works PredictÒ (Neural Ware, Inc., Carnegie, PA, USA). The 10 factors were used as input parameters (input neuron) to ANN ( Table 1) . The clinical patient outcome was assigned by an output neuron, giving a value 1 for recurrence-free status and a value 0 for non-recurrence free. The ANN included two hidden nodes chosen for obtaining best performance results. Each input neuron had a specific contribution to ANN outcome, as described in Table 1 . A total of 403 patients affected by urothelial bladder cancer were selected for the study. In all, 280 patients (69.4%) were used to train the system, while 123 (30.6%) were used for the testing phase. The input variable contribution to ANN output was expressed in a value ranging from 0 to 100, in accordance with their impact on ANN output. The contribution of each input variable in ANN analysis was also evaluated by using the difference between the original and modified neural net output. The use of ANN in bladder cancer patients allowed a sensitivity of 78.98% and a specificity of 97.86% in predicting recurrence-free status after surgical treatment at 12 months follow-up (positive predictive value 99.9% and negative predictive value 91.2%). The area under the ROC curve was 0.875. ANN analysis reported a high correlation between expectant and observed data. We reported a small difference between Pearson's coefficient values in different 'phase', indicating that the model generalises well and that it is likely to make accurate predictions when it processes new data, as described in Neural Works PredictÒ's instruction manual. Moreover, ANN analysis allows a prediction with an overall accuracy of 88.43%. This study stresses the fact that in tumour natural history and its follow-up decision making, we must use different approaches, due to the fact that tumour recurrence or progression is related to a complex network of independent variables. ANN, from this point of view, is able to analyse a non-linear relationship, by using multiple layers of interconnected nodes and achieve more accurate results [5] . 
